Market Tracker

07/22 6:45pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

11.03
Delayed Data
As of Jul 22
 +0.14 / +1.29%
Today’s Change
9.23
Today|||52-Week Range
56.16
-69.69%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close10.89
Today’s open10.96
Day’s range10.92 - 11.26
Volume306,827
Average volume (3 months)630,208
Market cap$318.7M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-114.61%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
VTAEVitae Pharmaceutical...+0.10+0.94%
AKBAAkebia Therapeutics ...+0.02+0.23%
TGTXTG Therapeutics Inc-0.21-3.48%
VSARVersartis Inc-0.04-0.36%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts